Even NextEra, which was already the biggest green energy builder in the country, realized its existing scale was insufficient to handle this massive wave of demand
doi: 10.1016/j.cgh.2023.06.004 Summary Keywords glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1 receptor, type 2 diabetes, metabolic dysfunction-associated steatohepatitis, obesity Citation Oe Y, Omori T, Aimono E, Furukawa S, Kitakawa H, Tateno M, Sakai K and Cho KY (2025) Case Report: Amelioration of severe metabolic dysfunction-associated steatohepatitis after switching from conventional GLP-1RAs to tirzepatide
Navarro-Pando et al., 2020)
[63] Blood pressure and renal function should be monitored closely during dose escalation